Precision neurology firm Bexorg, Inc. appoints industry veteran Dr. Mikael Dolsten as Chairman, marking a transition in corporate governance as co-founder Dr. Zvonimir Vrselja focuses on his ongoing role as CEO.
Bexorg announced the appointment of a new Chairman, a routine corporate governance change with no immediate financial impact.
Bexorg, Inc. has named Dr. Mikael Dolsten as the new Chairman of its Board of Directors, effective immediately. Dr. Dolsten succeeds co-founder Dr. Zvonimir Vrselja, who retains his role as Chief Executive Officer while remaining a member of the board.
Dr. Mikael Dolsten, M.D., Ph.D., has been appointed as the new Chairman of the Board of Directors.
Dr. Zvonimir Vrselja will continue to serve as the company's Chief Executive Officer and remains a member of the Board.